Product Program year 2025 Source: CMS Open Payments

Venclose Maven Catheter

Device Vascular/Oncology

PDI 00858254006398

Open in the dashboard

General payments

$614,237

4,237 payments

Research payments

$0

0 payments

Through program year 2025, $614,237 in general payments and $0 in research payments were reported against Venclose Maven Catheter (Vascular/Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $328,256 841
2024 General $162,978 1,801
2023 General $123,003 1,595

Breakdown

Who paid General payments · program years 2023–2025
  1. Bard Peripheral Vascular, Inc. $578,543 3,655 payments
  2. Becton, Dickinson and Company $34,777 559 payments
  3. Davol Inc. $525 18 payments
  4. C. R. Bard, Inc. & Subsidiaries $392 5 payments
Top recipients General payments · program year 2025
  1. Christopher Ninh Orthopaedic Surgery · Fountain Valley, CA $32,400 10% · 1 payment
  2. Our Lady Of Lourdes Memorial Hosp Teaching hospital · NY $32,400 10% · 1 payment
  3. North Shore Medical Center Teaching hospital · MA $32,400 10% · 1 payment
  4. Saint Vincent Hospital Teaching hospital · PA $24,300 7% · 1 payment
  5. Valley Medical Center Teaching hospital · WA $20,700 6% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Orthopaedic Surgery $32,400 26% · 1 practitioner
  2. Vascular Surgery Surgery $24,286 20% · 74 practitioners
  3. Cardiovascular Disease Internal Medicine $15,892 13% · 47 practitioners
  4. Internal Medicine $8,423 7% · 14 practitioners
  5. Interventional Cardiology Internal Medicine $8,194 7% · 52 practitioners

The top 5 of 50 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $57,388 17% · 37 recipients
  2. New York $44,545 14% · 24 recipients
  3. Massachusetts $32,558 10% · 3 recipients
  4. Pennsylvania $25,038 8% · 16 recipients
  5. Washington $20,700 6% · 1 recipient

The top 5 of 40 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

4,237 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record